Analysts See Up To 7% Upside
Key Highlights
- Paytm and Dr Lal PathLabs emerge as top technical picks for the week.
- Analysts see up to 7% upside in Paytm and 6% upside in Dr Lal PathLabs.
- Paytm buy range is around ₹1,279–₹1,280 with a target of ₹1,370.
- Dr Lal PathLabs is recommended near ₹1,750 with a target of ₹1,855.
- Stop-loss levels are ₹1,227 for Paytm and ₹1,687 for Dr Lal PathLabs.
- Recommendations are intended for short-term traders, not long-term investors.
- Experts advise strict adherence to stop-loss levels for effective risk management.
Technical analysts have identified Paytm (One97 Communications) and Dr Lal PathLabs as attractive short-term trading opportunities for the week, citing strong breakout formations and improving momentum on price charts.
According to technical market experts, Dr Lal PathLabs is showing positive signs after forming a strong support base. Traders are advised to consider buying the stock around ₹1,750, with a target price of ₹1,855. A stop-loss has been placed below ₹1,687 to limit downside risk. Based on the current technical setup, the stock offers a potential upside of around 6%.
Meanwhile, Paytm (One97 Communications) has also generated bullish technical signals. Analysts recommend accumulating the stock in the ₹1,279–₹1,280 range, with a short-term target of ₹1,370 and a stop-loss at ₹1,227. The projected upside for the stock is approximately 7%.
Market experts emphasize that these recommendations are based purely on technical chart analysis, including price action, breakout patterns, and momentum indicators. They are designed for short-term trading strategies rather than long-term investing.
Analysts also caution traders to maintain strict discipline by following stop-loss levels, as protecting capital remains equally important as capturing potential gains in volatile market conditions.
